This care model has grown in popularity, with startups such as Prenuvo and Ezra charging $2,500 out of pocket to screen asymptomatic patients for cancer and other diseases
“These findings suggest that changing the genetic testing paradigm to population-based testing could prevent thousands of breast and ovarian cancers," experts wrote in JAMA.
ACR noted that Congress is returning from its August recess, with one of the “most critical” considerations pertaining to government funding for fiscal 2025.
Digital breast tomosythesis now makes up close to 50% of mammography systems in the U.S. "Tomo is going to replace just straight digital mammography simply because of the benefit of fewer recalls," explained Debra L. Monticciolo, MD.
Rep. Greg Murphy, MD, R-N.C., unveiled the No Surprises Enforcement Act on Sept. 13, joined by Reps. Raul Ruiz, MD, D-Calif., and John Joyce, MD, R-Penn.
Continued declines in reimbursement and mounting administrative burdens are combining to weigh down members of the specialty, RP wrote in recent comments.